You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 9, September 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Infectious Diseases, Other
 •Kidney Transplantation
 •Dermatologic Procedures, Other
 •Alert me on articles by topic

VIGNETTES
Successful Thermotherapy for a Subcutaneous Infection Due to Alternaria alternata in a Renal Transplant Recipient

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cutaneous and subcutaneous deep tissue infections due to Alternaria species tend to occur most often in immunodepressed patients. The most common clinical form, alternariosis, is considered a paheohyphomycosis.1 More than 90 cases of cutaneous alternariosis have been reported, most of them in Europe.2

We present herein the first case to our knowledge of subcutaneous alternariosis that was healed without the use of antifungal or surgical treatment. This was achieved by applying only persistent thermotherapy.

Report of a Case

A 55-year-old white male gardener presented with a progressive right knee lesion. He underwent peritoneal dialysis for renal insufficiency due to nefroangiosclerosis. In April 2001, he received a heterotopic renal cadaver transplant, crossmatch negative, without any surgical or medical complications. Prior to transplantation, he was treated with 1 mg/kg of daclizumab (4 doses), and after transplantation he received 0.10 mg/kg per day of tacrolimus, 2 g/d of mycophenolate mofetil, and 90 mg/d of prednisone. He was . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION
Josep M. Torres-Rodríguez, MD; Meritxell Pérez González, MD; Josep M. Corominas, MD; Ramón M. Pujol, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.